Evaluation of a cyclophilin inhibitor in hepatitis C virus–infected chimeric mice in vivo
Kazuaki Inoue, Takuya Umehara, Urs T. Ruegg, Fumihiko Yasui, Tsunamasa Watanabe, Hiroshi Yasuda, Jean‐Maurice Dumont, Pietro Scalfaro, Makoto Yoshiba, Michinori Kohara – 28 March 2007 – Cyclosporin A (CsA) inhibits replication of the HCV subgenomic replicon, and this effect is believed to not be mediated by its immunosuppressive action. We found that DEBIO‐025, a novel non‐immunosuppressive cyclophilin inhibitor derived from CsA, inhibited HCV replication in vitro more potently than CsA.